Intended Use
Confirm whether the target disease, target patients, anatomical site, and clinical purpose are the same as those of previously approved devices.
APPLICATION CATEGORY
The approval application category is determined by the novelty of the product and its substantial equivalence to previously approved medical devices, not by device classification. The category affects how comparisons are made and how testing and clinical evaluation requirements are considered.
CATEGORY
A medical device whose structure, method of use, effect, or performance is clearly new
Determine the evidence needed to demonstrate effectiveness and safety according to the degree of novelty.
A medical device that does not fall into either the new or generic category
Explain the differences from previously approved devices and how those differences affect performance, safety, and clinical evaluation.
A medical device considered substantially equivalent to a previously approved medical device
Prepare comparative documentation demonstrating equivalence together with the necessary performance and safety data.
Actual application categories are determined individually based on the characteristics of the product to be submitted and comparison with previously approved devices.
RELATION TO RISK CLASS
Class I-IV classification is based on the risk a medical device poses to the human body. New, improved, and generic medical device categories, by contrast, relate to novelty and equivalence in an approval application.
Even within the same device class, the application category may differ when the structure or intended use is new. Products that fall within the scope of certification standards may also be certified by a Registered Certification Body rather than submitted for approval.
DECISION POINTS
Confirm whether the target disease, target patients, anatomical site, and clinical purpose are the same as those of previously approved devices.
Review differences in design, operating principle, materials, energy source, software, and other characteristics.
Compare operating steps, users, use environment, concomitant devices, duration of placement, and other conditions.
Review specifications, performance, risks, test methods, and acceptance criteria to determine whether additional evaluation is needed.
Assess whether the differences may affect clinical effectiveness or safety and whether clinical data are needed.
Assess whether the selected comparator appropriately represents the characteristics of the product to be submitted and provides the information needed for comparison.
PROCESS
Review the intended use, structure and principle of operation, method of use, specifications, materials, and risks from product documentation.
Use generic names, approval information, review reports, and public information to identify candidate comparators.
Present differences item by item and assess their impact on the safety and effectiveness of the product to be submitted.
Assess whether nonclinical testing and existing clinical data are sufficient or whether a new clinical study is needed.
Confirm the application documentation, testing, clinical evaluation, and need for PMDA consultation according to the category.
You can review PMDA information on the definitions of new, improved, and generic medical devices and approval review.
DOCUMENTATION
The method of comparison with previously approved devices and the scope of required documentation vary by application category. In practice, do not determine the evidence solely from the category name. Consider the characteristics of the product to be submitted and its differences from previously approved devices.
COMMON PITFALLS
FAQ
No. Device classification is based on the risk posed by the medical device. New, improved, and generic medical device categories relate to novelty and equivalence to previously approved devices in an approval application.
Not necessarily. Overseas marketing history alone does not determine the category. Compare the product with previously approved medical devices in Japan and assess whether the intended use, structure, method of use, performance, and other characteristics are substantially equivalent.
Yes. Improved medical devices include categories with and without clinical study data. Assess the clinical impact of the differences and whether nonclinical testing and existing data can adequately address them.
Testing may still be required. Documentation is needed to demonstrate substantial equivalence and conformity with the Essential Principles. Depending on the product characteristics, prepare performance, safety, sterilization, packaging, and other evidence.
If there is uncertainty about the application category or required documentation, consider the applicable PMDA consultation. Confirm the consultation type and scope using the latest PMDA guidance.
CONTACT
We review product information and overseas documentation, consider potential comparators and the expected application category, and organize the testing and clinical evaluation that may be required.
Related guide: Medical Device Approval Process in Japan · For application support: Approval, Certification & Notification Support
Contact us about the approval application category